...
首页> 外文期刊>ACS applied materials & interfaces >Ultrasensitive Fluorescent miRNA Biosensor Based on a 'Sandwich' Oligonucleotide Hybridization and Fluorescence Resonance Energy Transfer Process Using an Ln(III)-MOF and Ag Nanoparticles for Early Cancer Diagnosis: Application of Central Composite Design
【24h】

Ultrasensitive Fluorescent miRNA Biosensor Based on a 'Sandwich' Oligonucleotide Hybridization and Fluorescence Resonance Energy Transfer Process Using an Ln(III)-MOF and Ag Nanoparticles for Early Cancer Diagnosis: Application of Central Composite Design

机译:超敏感荧光miRNA生物传感器,基于“夹心核苷酸杂交和荧光共振能量转移工艺使用LN(III)-MOF和Ag纳米粒子用于早期癌症诊断:中央复合设计的应用

获取原文
获取原文并翻译 | 示例
           

摘要

Herein, a novel, rapid, highly sensitive, and selective fluorescent biosensor is presented, which is designed based on "sandwich-type" hybridization of oligonucleotides and the fluorescence resonance energy transfer (FRET) strategy. It senses and determines the MicroRNA-155 (miRNA-155) expression levels as a cancer biomarker. In this study, a modified La(III)-metal-organic framework(MOF) and silver nanoparticles (Ag NPs) were used as the energy donor-acceptor pairs in fluorescence quenching through the FRET process. La(III)-MOF was synthesized and then modified by glutaraldehyde as a cross-linking agent. The Ag NPs were also prepared, and then, the surface of both was conjugated with different 5'-amino-labeled ssDNA strands (aptamers). These prepared nanoprobes were characterized by various physicochemical techniques such as X-ray diffraction, energy-dispersive X-ray spectrometry, Fourier transform infrared, field emission scanning electron microscopy, UV-vis spectroscopy, elemental mapping, and gel electrophoresis. To optimize the detection conditions, several factors affecting biosensor performance were assessed by one variable-at-a-time and central composite design methods. Under optimum conditions, this "turn-off" fluorescent biosensor could detect and determine as low as 0.04 ppb (ng. mL(-1)) or 5.5 fM of the miRNA-155 biomarker. Therefore, this biosensor provides highly promising potential for lung and breast cancer diagnosis.
机译:本文,提出了一种新颖的,快速,高敏感和选择性的荧光生物传感器,其基于寡核苷酸的“夹心型”杂交和荧光共振能量转移(FRET)策略设计。它感测并确定作为癌症生物标志物的MicroRNA-155(miRNA-155)表达水平。在该研究中,使用改性的LA(III)型 - 有机骨架(MOF)和银纳米颗粒(Ag NPS)作为通过FRET过程的荧光猝灭中的能量供体对。合成La(III)-MOF,然后通过戊二醛作为交联剂改性。还制备了Ag NP,然后,两者的表面与不同的5'-氨基标记的SSDNA链(适体)缀合。这些制备的纳米素通过各种物理化学技术,例如X射线衍射,能量分散X射线光谱,傅里叶变换红外,场发射扫描电子显微镜,UV-Vis光谱,元素映射和凝胶电泳。为了优化检测条件,通过一个可变的AT-AT-AT-AT-AT-AT-AT-AT-AT-TIME和中央复合设计方法评估影响生物传感器性能的几个因素。在最佳条件下,该“关断”荧光生物传感器可以检测并确定低至0.04ppb(Ng。ml(-1))或miRNA-155生物标志物的5.5cm。因此,这种生物传感器为肺和乳腺癌癌症诊断提供了高度有希望的潜力。

著录项

相似文献

  • 外文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号